Advertisement

Topics

Pepperl+Fuchs GmbH Company Profile

20:21 EDT 25th September 2017 | BioPortfolio

Pepperl+Fuchs designs, produces and distributes electronic sensors and components for the global Automation market. Continuous innovation, enduring quality, and steady growth guarantees continued success.
The Factory Automation Division is a leading manufacturer of a wide range of industrial inductive, photoelectric and ultrasonic sensors. Complementing this line of mostly binary sensors, we also offer complex sensors, identification and communication systems.

The Process Automation Division is the market leader for intrinsically safe components and intrinsically safe decentralized peripherals. Our products easily connect with Fieldbus Components and allow the simple design of Fieldbus Topology.

Location

Königsberger Allee 87
Mannheim
68307
Germany

Contact

Phone: 49 (0)621 776-0
Fax: 49 (0)621 776-1000
Email: info@de.pepperl-fuchs.com


News Articles [189 Associated News Articles listed on BioPortfolio]

Stada bündelt Vertriebsgesellschaften in Deutschland

FRANKFURT (Dow Jones)--Der Arzneimittelkonzern Stada bündelt seine Geschäftsaktivitäten in Deutschland. Die bisher vier Vertriebsgesellschaften Stadavita GmbH, Stada GmbH, cell pharm GmbH und Stad....

Original-Research: WILEX AG (von EQUITS GmbH): Kaufen

Original-Research: WILEX AG - von EQUITS GmbH Einstufung von EQUITS GmbH zu WILEX AG Unternehmen: WILEX AG ISIN: DE000A11QVV0 Anlass der Studie: Coverage Aufnahme Empfehlung: Kaufen seit: 19.05.20...

DGAP-News: GBC Kapital GmbH: Erfolgreich abgeschlossene Kapitalmaßnahme der SYGNIS AG - beide Kapitalerhöhungen wurden von der GBC Kapital GmbH und der MC Services AG, jeweils als Co-Lead Manager Institutional Sales, begleitet und waren signifikant

GBC Kapital GmbH: Erfolgreich abgeschlossene Kapitalmaßnahme der SYGNIS AG - beide Kapitalerhöhungen wurden von der GBC Kapital GmbH und der MC Services AG, jeweils als Co-Lead Manager Institution.....

AudioCure Pharma GmbH appoints Dr. Reimar Schlingensiepen as CEO

Dr. Reimar Schlingensiepen succeeds Prof. Hans Rommelspacher, the founder of AudioCure, as CEO Prof. Rommelspacher will continue as CSO AudioCure recently secured funding of about 9 million euros from...

Körber Plans Takeover of Systec Services GmbH

     (Photo: http://mma.prnewswire.com/media/558312/SystecServices_Headquarters.jpg) With the planned takeover, Körber Medipak Systems GmbH, the holding company of Business Area Pharma Systems...

Original-Research: Valneva SE (von First Berlin Equity Research GmbH): BUY

Original-Research: Valneva SE - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Valneva SE Unternehmen: Valneva SE ISIN: FR0004056851 Anlass der Studie: U...

wikifolio whispers p.m. zu Nemetschek, Microsoft, Fuchs Petrolub ...

Aktuelle Kommentare aus dem wikifolio-Universum. Mit Links zu den jeweiligen Depots, damit man sieht, wie erfolgreich die Kommentatoren mit ihren Einschätzungen sind und wie sich die genannten Inpu.....

wikifolio whispers p.m. zu Fuchs Petrolub, Zumtobel, Biogen Idec ...

Aktuelle Kommentare aus dem wikifolio-Universum. Mit Links zu den jeweiligen Depots, damit man sieht, wie erfolgreich die Kommentatoren mit ihren Einschätzungen sind und wie sich die genannten Inpu.....

PubMed Articles [45 Associated PubMed Articles listed on BioPortfolio]

Descemetorhexis Without Grafting for Fuchs Endothelial Dystrophy-Supplementation With Topical Ripasudil.

To report the safety and efficacy of descemetorhexis without grafting as a primary intervention in Fuchs dystrophy, and the use of a ROCK inhibitor, ripasudil as a salvage agent in failing cases.

Trinucleotide Repeat Expansion in the Transcription Factor 4 (TCF4) Gene Leads to Widespread mRNA Splicing Changes in Fuchs' Endothelial Corneal Dystrophy.

To identify RNA missplicing events in human corneal endothelial tissue isolated from Fuchs' endothelial corneal dystrophy (FECD).

Changes in lipidomic profile of aqueous humour in Fuchs endothelial dystrophy.

To identify and determine differences in lipid profile of aqueous humour (AH) in patients with Fuchs endothelial corneal dystrophy (FECD).

Identification of Circulating Fibrocytes and Dendritic Derivatives in Corneal Endothelium of Patients With Fuchs' Dystrophy.

Fuchs' endothelial corneal dystrophy (FECD) is a degenerative eye disorder affecting 4% of Americans older than 40. It is the leading indication for corneal endothelial (CE) transplantation for which ...

Elimination of Anterior Corneal Steepening With Descemet Membrane Endothelial Keratoplasty in a Patient With Fuchs Dystrophy and Keratoconus: Implications for IOL Calculation.

To report a case of coexistent Fuchs endothelial corneal dystrophy (FECD) and keratoconus (KCN) in which there was normalization of corneal topography after Descemet membrane endothelial keratoplasty ...

Clinical Trials [45 Associated Clinical Trials listed on BioPortfolio]

Fuchs' Torsional Phaco Study

The primary objective is to compare the effect of torsional phacoemulsification and longitudinal phacoemulsification on central and peripheral corneal thickness/volume after cataract surge...

DMEK Versus DSAEK Study

The purpose of this study is to determine whether corneal transplantation by Descemet Membrane Endothelial Keratoplasty more favourable and cost-effective is compared to Descemet Stripping...

A Study Investigating the Safety, Tolerability, and Efficacy of MTP-131 Topical Ophthalmic Solution for the Treatment of Fuchs' Corneal Endothelial Dystrophy (FCED)

This is a Phase 1/2, prospective, randomized, double-masked, vehicle controlled, paired-eye study in approximately 16 subjects to evaluate safety, tolerability and efficacy of MTP-131 opht...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Companies [522 Associated Companies listed on BioPortfolio]

Pepperl+Fuchs GmbH

Pepperl+Fuchs designs, produces and distributes electronic sensors and components for the global Automation market. Continuous innovation, enduring quality, and steady growth guarantees continued succ...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

Praher Beteiligungs GmbH

The vision of the company founder Ludwig Praher to produce better and better products of high-grade plastics was the basis for sound growth. Under the direction of Ing. Winfried Praher and Ewald Prahe...

Ormecon GmbH

Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...

More Information about "Pepperl+Fuchs GmbH" on BioPortfolio

We have published hundreds of Pepperl+Fuchs GmbH news stories on BioPortfolio along with dozens of Pepperl+Fuchs GmbH Clinical Trials and PubMed Articles about Pepperl+Fuchs GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pepperl+Fuchs GmbH Companies in our database. You can also find out about relevant Pepperl+Fuchs GmbH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record